These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3071240)

  • 21. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort.
    Grover SA; Palmer CS; Coupal L
    Arch Intern Med; 1994 Mar; 154(6):679-84. PubMed ID: 8129502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
    Miller M; Zhan M; Havas S
    Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does HDL-cholesterol determination facilitate the assessment of risk in coronary patients?].
    Schmid B; Hartmann G
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1923-5. PubMed ID: 6665537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
    Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
    Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2006 Nov; 98(9):1231-3. PubMed ID: 17056335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids and lipoproteins as risk indicators for coronary heart disease (a study on male patients with defined vessel findings).
    Herrmann W; Schütz C; Hanf S; Lindhofer HG; Schmidt H; Strauss HJ; Schaedel H; Oswald B
    Przegl Lek; 1989; 46(7):604-10. PubMed ID: 2587789
    [No Abstract]   [Full Text] [Related]  

  • 30. [Are apolipoproteins better indicators of ischemic heart disease than serum lipids?].
    Klosiewicz-Latoszek L
    Kardiol Pol; 1989; 32(1):41-9. PubMed ID: 2681921
    [No Abstract]   [Full Text] [Related]  

  • 31. Apolipoproteins and risk of coronary heart disease.
    Connelly PW
    CMAJ; 1991 May; 144(10):1277. PubMed ID: 2025824
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoproteins as markers for coronary heart disease.
    Butman B; Taddei-Peters W; Ransom J
    Am Biotechnol Lab; 1992 Oct; 10(10):36. PubMed ID: 1368779
    [No Abstract]   [Full Text] [Related]  

  • 33. Determining lipid risk factors for coronary heart disease.
    Gelskey DE; Fox JG; Hammond GW
    CMAJ; 1989 Mar; 140(5):493. PubMed ID: 2634969
    [No Abstract]   [Full Text] [Related]  

  • 34. [Physiological significance of human apolipoproteins].
    Kostner GM
    Acta Med Austriaca Suppl; 1977; (4):74-5. PubMed ID: 269614
    [No Abstract]   [Full Text] [Related]  

  • 35. Utility of different lipid measures to predict coronary heart disease.
    Remick J; Underberg JA; Shah NR
    JAMA; 2008 Jan; 299(1):35-6; author reply 36. PubMed ID: 18167402
    [No Abstract]   [Full Text] [Related]  

  • 36. Utility of different lipid measures to predict coronary heart disease.
    Sierra-Johnson J; Romero-Corral A; Lopez-Jimenez F
    JAMA; 2008 Jan; 299(1):35; author reply 36. PubMed ID: 18167403
    [No Abstract]   [Full Text] [Related]  

  • 37. Methods to identify increased risk of coronary disease in the general population: conclusion is oversimplification.
    Assmann G; Cullen P; Schulte H
    BMJ; 2003 Sep; 327(7415):619; author reply 619. PubMed ID: 12969938
    [No Abstract]   [Full Text] [Related]  

  • 38. [Apolipoproteins and screening for coronary atherosclerosis].
    Cano Y; Malandain H
    Presse Med; 1983 Apr; 12(19):1236. PubMed ID: 6221307
    [No Abstract]   [Full Text] [Related]  

  • 39. Severity of coronary artery disease and serum lipid levels.
    Batalla A; Reguero JR; Hevia S; Sieres M; Raviña T
    Int J Cardiol; 2001 Apr; 78(2):201-2. PubMed ID: 11398771
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multivalidation analysis of the risk factors for ischemic heart disease and cerebral infarction].
    Kawamoto T; Sasaki H; Horiuchi I; Hino F; Ohki M; Nishimura S; Tazuma S; Tokumo H; Nomura Y; Hiraoka T
    Nihon Ronen Igakkai Zasshi; 1985 Nov; 22(6):550-7. PubMed ID: 3831460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.